Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any cleft lip/palate in which the cause of the disease is a mutation in the DLX4 gene.
Features include always present findings: Euryblepharon, Lagophthalmos, Sparse eyebrow, and Bilateral cleft lip and others; and common findings: Epicanthus, Upslanted palpebral fissure, Inguinal hernia, and Midface retrusion and others. 22 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Head and neck | 3 | Bilateral cleft lip, Palate fistula, Bilateral cleft palate |
DLX4 encodes distal-less homeobox 4 (240 aa). May play a role in determining the production of hemoglobin S. May act as a repressor. During embryonic development, plays a role in palatogenesis Highest expression in Skin Sun Exposed Lower leg (3.0 TPM) and Skin Not Sun Exposed Suprapubic (2.2 TPM).
Orofacial cleft 15 is associated with mutations in the DLX4 gene on chromosome 17.
The DLX4 protein participates in Transcriptional Regulation by VENTX pathway.
DLX4 is classified as a druggable target with score 6.5.
Genetic testing for DLX4 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for orofacial cleft 15 has been reported in the published literature.
Phenotype severity distribution: 7 always present features, 14 common features.
No clinical trials have been registered for orofacial cleft 15.
48 publications have been identified in PubMed for orofacial cleft 15. Research spans Epidemiology / Natural History (29%), Basic Science / Preclinical (27%), and Review / Meta-Analysis (17%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 14 | 29% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 4:28 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Brain and nerves |
1 |
Hyponasal speech |
13 |
27% |
Research summaries | 8 | 17% |
Patient case studies | 4 | 8% |
Clinical study results | 4 | 8% |
Other research | 2 | 4% |
New treatment approaches | 2 | 4% |
Testing and diagnosis research | 1 | 2% |
Wong L (2026). [PMID: 39632721](https://pubmed.ncbi.nlm.nih.gov/39632721/). *Cleft Palate Craniofac J*. [Epidemiology / Natural History]
Hing A (2026). [PMID: 40223296](https://pubmed.ncbi.nlm.nih.gov/40223296/). *Cleft Palate Craniofac J*. [Review / Meta-Analysis]
Kandi LA (2026). [PMID: 41739540](https://pubmed.ncbi.nlm.nih.gov/41739540/). *Cleft Palate Craniofac J*. [Review / Meta-Analysis]
Tillman KK (2026). [PMID: 41545270](https://pubmed.ncbi.nlm.nih.gov/41545270/). *J Plast Reconstr Aesthet Surg*. [Epidemiology / Natural History]
Kabuyaya MK (2026). [PMID: 40223304](https://pubmed.ncbi.nlm.nih.gov/40223304/). *Cleft Palate Craniofac J*. [Epidemiology / Natural History]
Silva A (2026). [PMID: 41912658](https://pubmed.ncbi.nlm.nih.gov/41912658/). *J Hum Genet*. [Epidemiology / Natural History]
Mukanahayo E (2026). [PMID: 41490861](https://pubmed.ncbi.nlm.nih.gov/41490861/). *BMJ Open*. [Basic Science / Preclinical]
Hojati M (2026). [PMID: 42082937](https://pubmed.ncbi.nlm.nih.gov/42082937/). *BMC Pregnancy Childbirth*. [Review / Meta-Analysis]
Herrick N (2026). [PMID: 41674607](https://pubmed.ncbi.nlm.nih.gov/41674607/). *medRxiv*. [Basic Science / Preclinical]
Kennedy C (2026). [PMID: 40095985](https://pubmed.ncbi.nlm.nih.gov/40095985/). *Cleft Palate Craniofac J*. [Epidemiology / Natural History]